BAYERCROPBayer CropScience Ltd.
Bayer CropScience Q2 FY27 Results: Standalone Net Profit ₹166 Crore on Total Income of ₹1,264 Crore
- Earnings
- Agrochemicals and seeds
Reviewed byKeshav SehgalBlacklitt Research
Bayer CropScience (NSE: BAYERCROP) reported a standalone total income of ₹1,264 crore and net profit of ₹166 crore for the quarter ended 30 Sep 2026, it said in a filing on 03 Nov 2026. The company has no subsidiary, so no consolidated results were reported.
Key highlights
Standalone
The company on its own, without its subsidiaries
- Total income: ₹1,264 crore, down 19.3% YoY and 34.3% QoQ
- Net profit and EPS: ₹166 crore, up 8.8% YoY; basic EPS ₹36.98
- Interim dividend: ₹90 per share, ₹404.5 crore in total, record date 12 Nov 2026
- Other income: ₹13 crore, with no divestment gain in the quarter
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 1,264 | 1,567 | -19.3% | 1,924 | -34.3% | |
| Revenue from operations | 1,251 | 1,553 | -19.5% | 1,835 | -31.8% |
| Other income | 13 | 14 | -2.9% | 89 | -84.9% |
| 166 | 153 | +8.8% | 322 | -48.3% | |
| Profit before tax | 211 | 200 | +5.5% | 402 | -47.4% |
| Finance costs | 5 | 4 | +6.8% | 4 | +9.3% |
| Depreciation | 15 | 14 | +4.2% | 50 | -70.1% |
| Tax expense | 45 | 48 | -5.0% | 81 | -43.9% |
| Net profit margin | 13.15% | 9.74% | +3.40 pp | 16.72% | -3.57 pp |
| EPS, basic (₹) | 36.98 | 33.98 | +8.8% | 71.56 | -48.3% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
The company reports one business segment, AgriCare. The statutory auditor, Deloitte Haskins & Sells LLP, issued a limited review report that noted no material misstatement.
Trade receivables rose to ₹18,198 million from ₹11,155 million at 31 Mar 2026, while cash and cash equivalents fell to ₹4,709 million from ₹14,146 million, according to the balance sheet notes.
Inference
The Board declared an interim dividend of ₹90 per equity share for FY 2026-27, amounting to ₹4,045 million, with the record date fixed at 12 Nov 2026 and payment on 30 Nov 2026. Dividends paid in the six months rose to ₹2,694 million from ₹1,572 million a year earlier.
Other equity rose to ₹31,394 million from ₹29,208 million at 31 Mar 2026. The filing does not state the reason for the fall in cash or the rise in trade receivables, nor whether the quarter includes any exceptional items.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
